Armaceutica, Inc.
🇺🇸United States
Malaria Drug Pyronaridine Shows Promise as Novel Cancer Treatment
• UTEP researchers secure patent for repurposing pyronaridine, a 30-year-old antimalarial drug, as a potential cancer treatment targeting multiple cancer types.
• The drug demonstrates a triple mechanism of action: slowing cancer cell growth, inducing programmed cell death, and showing minimal impact on healthy cells.
• Initial pilot studies by Armaceutica on late-stage cancer patients showed increased longevity, though further clinical trials are needed to validate safety and efficacy.
© Copyright 2025. All Rights Reserved by MedPath